You searched for "blindness"
Strengthening diabetic retinopathy services in Nigeria through DR-NET – from grass roots to national policy development
3 August 2023
| Oteri Okolo, Dennis Nkanga, Hannah Faal, Marcia Zondervan, Covadonga Bascaran
|
EYE - General
This is the third article in a series (see Part 1 and Part 2) reflecting on how shared learning via networks of UK and international eye health professionals is contributing to reducing unnecessary blindness in Nigeria. Earlier articles focused on...
Michael Burdon to begin term of office as a BCPB Trustee
17 June 2020
Michael Burdon begins his term of office as a BCPB Trustee in July 2020, and in October 2020 will become Chairman of the Council when Paul Hunter retires after six years.
Governments missing opportunity to increase economic progress
Report calls on governments to invest in eye health to address $410.9 billion loss in economic productivity.Edinburgh local plans to run Scottish half marathon for Fight for Sight
A local to Edinburgh and East Lothian who suffers from Stargardts disease will run the Scottish half marathon to fundraise for Fight for Sight.
Effects of ML4 on the eye
3 October 2023
| Fiona Rowe (Prof)
|
Paediatric Ophthalmology / Strabismus
Mucolipidosis type IV (ML4) is an autosomal recessive lysosomal storage disease and is caused by variants of the MC0LN1 gene. It often presents in young individuals with eye and ocular adnexa issues. The authors present a case report and literature...
Orbis and FundamentalVR to talk at 100% Optical
The health care technology company teams up with the global non-profit to showcase how simulation, telemedicine and virtual reality (VR) are changing the landscape of cataract surgery education.Glaucoma UK and The Royal College of Ophthalmologists announce research award 2024
Glaucoma UK and The Royal College of Ophthalmologists are collaborating to run this prestigious award which has previously funded a range of research topics from prospective stem cell treatments to the use of big data in patient risk stratification.
Transfected RPE cells inhibit AMD in rats
1 August 2015
| Graham Wallace
|
Retina / Uvea / Vitreous
|
Age-related macular degeneration, Choroidal neovascularization, Fibulin-5, Retinal pigment epithelium, Transplantation
Age-related macular degeneration (AMD) is a leading cause of blindness in the elderly. Wet AMD is characterised by choroidal neovascularisation, new vessels into the retina, leading to leakage and tissue damage. Many proangiogenic factors particularly vascular endothelial growth factor (VEGF)...
Outcomes of ‘treat and extend’ for neovascular AMD
1 August 2015
| Brian Ang
|
Retina / Uvea / Vitreous
The authors report on 24-month outcomes of anti-vascular endothelial growth factor (anti-VEGF) therapy using a ‘treat and extend’ regime for treatment-naïve neovascular age-related macular degeneration (nAMD). Data for this study was collected from the Fight Retinal Blindness observational registry based...
Impact of WASH factors on trachoma prevalence
4 December 2024
| Nishita Patel
|
EYE - Cornea
Trachoma is the leading infectious cause of blindness globally. Following a national population-based trachoma survey in Malawi, one round of azithromycin mass drug elimination (MDA) was carried out successfully – that is, the prevalence of trachomatous inflammation, follicular (TF) in...
In conversation with Yasmin El-Rouby
2 February 2024
| Yasmin El-Rouby
|
EYE - General
Author and Eye Doctor, Dr Yasmin El-Rouby, wishes to raise awareness about common vision disorders. Envisioning a world where preventable eye conditions are caught early, she founded Baseera, a non-profit organisation, to improve access to basic eyecare in developing countries....
Moorfields: The 2025 macula course
2 June 2025
-5 June 2025
The 2025 Macula course will take place from 2nd - 5th June 2025. Bookings are now open. Retinal diseases are a major cause of blindness. Diagnostic investigations, understanding of disease mechanisms, new therapies, and the evidence base, have all evolved...
